San Diego’s Quidel Corp. boosted its fourth quarter sales forecast on Thursday after the omicron and delta variants sparked increased demand for its rapid at-home COVID-19 tests. The company, which ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has ...
Quidel Corporation QDEL recently confirmed the efficacy of its antigen tests concerning continued detection of COVID-19 variants, including Omicron. The company has been at the forefront of the battle ...
Quidel Corp., based in San Diego, announced it closed May 27 on the previously announced acquisition of Raritan-based Ortho Clinical Diagnostics Holdings PLC. The deal — which would create a new ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Quidel Corporation QDEL recently entered into a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc OCDX. The transaction, which is subject to approval of both the companies’ ...
Raritan’s Ortho Clinical Diagnostics Holdings plc and Quidel Corp., based in San Diego, on Dec. 23 announced entering a definitive agreement that will see Quidel acquire Ortho in a deal valued at ...
Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results